| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1440-1711.2001.01022.X |
| P698 | PubMed publication ID | 11488983 |
| P2093 | author name string | K Namba | |
| A Taylor | |||
| P433 | issue | 4 | |
| P304 | page(s) | 358-367 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Immunology & Cell Biology | Q13731918 |
| P1476 | title | In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) | |
| P478 | volume | 79 |
| Q35629987 | Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis |
| Q36421662 | Alpha-MSH regulates protein ubiquitination in T cells |
| Q37206399 | Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents |
| Q37827463 | Applications of the role of α-MSH in ocular immune privilege. |
| Q28298659 | Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice |
| Q35227663 | Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages |
| Q88760563 | Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH2 Template |
| Q36993520 | Evidence for phenotypic plasticity in response to photic cues and the connection with genes of risk in schizophrenia |
| Q37535138 | Immune escape mechanisms of intraocular tumors |
| Q34342577 | Inducible immune regulation following autoimmune disease in the immune-privileged eye |
| Q41959945 | Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis |
| Q38287475 | Intracellular signaling mechanisms of the melanocortin receptors: current state of the art. |
| Q37632054 | Leveraging melanocortin pathways to treat glomerular diseases |
| Q28083298 | Manipulating regulatory T cells: a promising strategy to treat autoimmunity |
| Q37599583 | Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis |
| Q26865343 | Melanocortin peptides: potential targets in systemic lupus erythematosus |
| Q41552761 | Melanocortins, Melanocortin Receptors and Multiple Sclerosis |
| Q46749636 | Morph-specific genetic and environmental variation in innate and acquired immune response in a color polymorphic raptor |
| Q21558407 | Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone |
| Q50065340 | Negative regulators that mediate ocular immune privilege |
| Q38868323 | Neuropeptide substance P and the immune response |
| Q26767508 | Ocular Immune Privilege and Transplantation |
| Q42200330 | Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? |
| Q91292013 | PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease |
| Q34049621 | Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke. |
| Q36691091 | Regulation of immune tolerance by anti-inflammatory neuropeptides |
| Q35092535 | Regulatory T cells in transplantation tolerance |
| Q34786943 | Regulatory T cells in transplantation. |
| Q38710638 | The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids |
| Q38501748 | The alpha-melanocyte stimulating hormone induces conversion of effector T cells into treg cells |
| Q41975249 | The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy |
| Q36422266 | The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. |
| Q35069961 | The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties |
| Q35609371 | Tregs and infections: on the potential value of modifying their function |
| Q33793694 | Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder |
| Q44663230 | α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation |
| Q34627621 | α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke |
Search more.